Last updated: 2026-09-06 03:09:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Nautilus Biotechnolgy, Inc. (NAUT) operates in the LABORATORY ANALYTICAL INSTRUMENTS sector and is listed on NASDAQ. The stock is currently priced at $0.90, with a market capitalization of $122.39M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.62 to $4.31. This page covers its latest market performance, valuation, price trends and company information.
$122.39M | |
$0.91 | |
$12.38 | |
$0.62 | |
$0.92 | |
540.49K | |
-- | |
-- | |
$4.31 | |
$0.62 | |
-- | |
-- |
Nautilus Biotechnolgy, Inc. (NAUT) last closed at $0.92 as of 2026-09-05 00:00:00, unchanged from the previous close of $0.92.
During the latest regular trading session, NAUT traded between $0.62 and $12.38, with a volume of 540.49K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Over the past seven days, Nautilus Biotechnolgy, Inc. (NAUT) moved from $0.90 to $0.90, representing a gain of 0.44% ($0.00).
The stock traded between $0.89 and $0.94 during the period. The latest price is near the lower end of the 7-day range, indicating range-bound.
The average daily volume was 654.22 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 7.7%
NAUT is currently trading at $0.90, placing it 7.7% of the way from its 52-week low of $0.62 to its 52-week high of $4.31. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Its products includes: Proteome Analysis System, Reagent Kits, Software and analysis.
| Industry | LABORATORY ANALYTICAL INSTRUMENTS |
| Employees | 130 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Nautilus Biotechnolgy, Inc. (NAUT) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.